24 HR selegiline 0.25 MG/HR Transdermal System — RxCUI 865206
RxNorm drug concept · Semantic clinical drug
RxCUI 865206
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI865206
Official name24 HR selegiline 0.25 MG/HR Transdermal System
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asselegiline 6 MG/Day 24 HR Transdermal Patch; selegiline 6 MG/Day 24HR Transdermal System; selegiline 0.25 MG/HR 24 HR Transdermal Patch
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)984 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Selegiline Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Emsam is a prescription skin patch used to treat major depressive disorder (MDD) in adults. It belongs to a class of antidepressants called MAOIs — monoamine oxidase inhibitors — w...
- What is the Emsam patch actually used for?
- It depends on your dose. At the lowest dose, no special diet is required. But at the two higher doses, you do need to avoid foods high in tyramine — things like aged cheeses, cured...
- Do I really need to avoid certain foods while wearing this patch?
🕸️ Concept Web — How 24 HR selegiline 0.25 MG/HR Transdermal System Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
24 HR selegiline 0.25 MG/HR Transdermal System
RxCUI 865206 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Selegiline
9639IN
-
Selegiline
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Emsam
617716BN
-
Emsam
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Selegiline Transdermal System
1806068SCDF -
Selegiline Topical Product
1158174SCDG -
Selegiline Transdermal Product
1295063SCDG -
Selegiline Transdermal System [Emsam]
1806071SBDF -
Emsam Topical Product
1175941SBDG -
Emsam Transdermal Product
1296229SBDG -
Transdermal System
316987DF -
Topical Product
1151122DFG - +1 more in this family
-
Selegiline Transdermal System
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Selegiline 0.25 MG/HR
1806067SCDC -
24 HR selegiline 0.25 MG/HR Transdermal System [Emsam]
865208SBD -
Selegiline 0.25 MG/HR [Emsam]
1806070SBDC
-
Selegiline 0.25 MG/HR
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Selegiline 0.25 MG/HR
SCDC · 1806067 -
Selegiline Transdermal System
SCDF · 1806068 -
Selegiline Topical Product
SCDG · 1158174 -
Selegiline Transdermal Product
SCDG · 1295063
Brand-Name Concepts
-
24 HR selegiline 0.25 MG/HR Transdermal System [Emsam]
SBD · 865208 -
Selegiline 0.25 MG/HR [Emsam]
SBDC · 1806070 -
Selegiline Transdermal System [Emsam]
SBDF · 1806071 -
Emsam Topical Product
SBDG · 1175941 -
Emsam Transdermal Product
SBDG · 1296229 -
Emsam
BN · 617716
📦 FDA Products & Package NDCs
3 products · 4 package NDCs
4 package NDCs map to RxCUI 865206 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 49502-0900-05 | 5 POUCH in 1 CARTON (49502-900-05) / 1 PATCH in 1 POUCH (49... | EMSAM | Viatris Specialty LLC | 2006-02-27 |
| 49502-0900-30 | 30 POUCH in 1 CARTON (49502-900-30) / 1 PATCH in 1 POUCH (4... | EMSAM | Viatris Specialty LLC | 2006-02-27 |
| 49502-0901-30 | 30 POUCH in 1 CARTON (49502-901-30) / 1 PATCH in 1 POUCH (4... | EMSAM | Viatris Specialty LLC | 2006-02-27 |
| 49502-0902-30 | 30 POUCH in 1 CARTON (49502-902-30) / 1 PATCH in 1 POUCH (4... | EMSAM | Viatris Specialty LLC | 2006-02-27 |
Observed labelers:
Viatris Specialty LLC (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.